Media
Presentations

Corporate Presentation
Download Presentation
Videos
OKYO Pharma reaches milestone with first patient screening for dry eye disease trial
OKYO Pharma granted new patent for OK-101 to treat neuropathic pain
OKYO Pharma to take dry eye disease drug direct into Phase 2 clinical trials
OKYO CEO Gary Jacob talks to Jane King about the progress of the phase 2 trial with OK-101